The health and safety of our patients, families and staff is our highest priority. Due to the COVID-19 pandemic, the Commonwealth of Massachusetts is requiring hospitals to meet established criteria as part of the state’s reopening plan. The Boston Shriners Hospital completed its Phase 1 attestation on May 27, 2020, and its Phase 2 attestation on June 15, 2020 and its Phase 3 attestation on July 13, 2020. The Phase 3 attestation was resubmitted and reaffirmed on November 16, 2020. The Boston Shriners Hospital also completed and submitted the state’s resurgence attestation on November 16, 2020.

If your child has an upcoming appointment, please contact your local Shriners Hospitals for Children location.

Shriners Hospitals for Children — Boston visitor information.

Skip to navigation

Elizabeth Van Cott, M.D.

Elizabeth Van Cott, M.D., is on the active medical staff in pathology at Shriners Hospitals for Children — Boston. She earned a medical degree from Harvard Medical School, completed her residency at Massachusetts General Hospital (MGH) and is board certified by the American Board of Pathology.

Dr. Van Cott is director of the coagulation laboratory and medical director of the core laboratory at MGH and professor of pathology at Harvard Medical School. She served two terms as president of the North American Specialized Coagulation Laboratory Association (NASCOLA). She serves as an advisor for the Area Committee on Hematology for the Clinical and Laboratory Standards Institute (CLSI), and is actively involved in writing coagulation laboratory guidelines for CLSI. She served a six-year term as an inaugural member of the new standards committee of the College of American Pathologists (CAP), and she completed a six-year term on the CAP Coagulation Resource Committee.

Dr. Van Cott has published over 150 publications in the field of coagulation. She holds positions of associate editor, section editor or editorial board member for multiple journals. She served on the steering committee for the first THSNA (Thrombosis and Hemostasis Societies of North America) summits in 2012, 2014 and 2016, and serves on the inaugural THSNA board of directors. She was an invited expert participant at the two most recent CAP consensus conferences in coagulation which generated consensus guidelines on Laboratory Monitoring of Anticoagulant Therapy as well as Thrombophilia.


  • Medical Degree, Harvard Medical School
  • Residency, Massachusetts General Hospital

Board certifications:

  • Clinical Pathology, American Board of Pathology